These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18104958)

  • 1. [Previous jaundice in Morgagni-Läennec liver cirrhosis].
    GALLO V
    Minerva Med; 1948 Nov; 39(46 Pt 2):519-23. PubMed ID: 18104958
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anatomical alterations of intrahepatic blood vessels in Morgagni-Laennec cirrhosis].
    MONTAGNANI CA; PACI G
    Boll Soc Ital Biol Sper; 1952 Jul; 28(7):1439-41. PubMed ID: 13018806
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morgagni-Laennec cirrhosis; clinicostatistical study of 137 cases].
    LUSIANI GB; SALVI A
    Omnia Ther Suppl; 1955; 33(3-4):129-74. PubMed ID: 13289007
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of changes in the portal lymph nodes in liver cirrhosis of Morgagni-Laënnec; liver cirrhosis and portal lymph circulation].
    CECCHI G; INFRANZI A
    Riforma Med; 1955 Jun; 69(23):626-36. PubMed ID: 13246461
    [No Abstract]   [Full Text] [Related]  

  • 5. [New etiopathogenetic concepts and modern therapy of Morgagni-Laënnec liver cirrhosis].
    CAMPANA C
    Policlinico Prat; 1949 Jan; 56(4):97-111. PubMed ID: 18109675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemoglobin metabolism in Morgagni-Laennec cirrhosis].
    LATTANZI A
    Riv Gastroenterol; 1950; 2(5):241-67. PubMed ID: 14817009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on liver cirrhosis. III. Megaloblastic anemia during Morgagni-Laennec cirrhosis].
    FALZOI M; MAGNANI B
    Prog Med (Napoli); 1953 Aug; 9(16):494-501. PubMed ID: 13112283
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sodium retention as a cause of ascites in Morgagni-Laennec cirrhosis].
    D'AMICO G
    Arch Patol Clin Med; 1956; 32(5):353-73. PubMed ID: 13341373
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modifications of glucides metabolism in Morgagni-Laennec cirrhosis].
    SCOTTI G
    Riv Gastroenterol; 1952; 4(6):265-84. PubMed ID: 13014916
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinicostatistical study on 308 cases of Morgagni-Laennec liver cirrhosis].
    NICROSINI F
    G Clin Med; 1958 Aug; 39(8):1171-204. PubMed ID: 13609995
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver cirrhosis. II. Hemolysis in the pathogenesis of the normocytic and macrocytic anemia of Morgagni-Laennec cirrhosis; hemoglobin metabolism and variations induced by lipotropic factor therapy].
    FALZOY M; D'ANTUONO G; ORLANDO E
    G Clin Med; 1952 Jun; 33(6):575-90. PubMed ID: 12989544
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aspects of hypophyso-adrenal cortex function in liver cirrhosis of Morgagni-Laennec].
    Piotti LE; Ferrari E; Bossolo PA; Carullo P
    Epatologia; 1970; 16(6):571-83. PubMed ID: 5525606
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anatomico-clinical studies of combined Morgagni-Laennec liver cirrhosis and malignant tumors].
    CARINCI MP
    Riv Gastroenterol; 1956; 8(6):173-85. PubMed ID: 13421470
    [No Abstract]   [Full Text] [Related]  

  • 14. [Association of a synthetic anabolizer, 4-chlorotestosterone acetate, with prednisone in the treatment of ascitogenic Morgagni-Laennec liver cirrhosis].
    BISARO A; CASASOLA M; MILESI C; GENERO RE
    Minerva Med; 1959 Feb; 50(13):449-59. PubMed ID: 13643875
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasmatic fatty acis in Morgagni-Laennec hepatic cirrhosis].
    Salvioli GF; Vecchi GP
    Minerva Gastroenterol; 1967; 13(1):8-11. PubMed ID: 5602602
    [No Abstract]   [Full Text] [Related]  

  • 16. [New experiences on treatment of ascites in the Morgagni-Laënnec cirrhosis by means of reinfusion of autogenous ascitic fluid].
    Barlattani M; Alessandrini A; Vecchi L
    Clin Ter; 1965 Aug; 34(3):210-28. PubMed ID: 5849857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Introduction to the epidemiological study of hepatic cirrhosis (postnecrotic and Morgagni-Läennec) and of hepatocarcinomas in Minas Gerais, Brazil].
    Guimarães RC
    Rev Inst Med Trop Sao Paulo; 1971; 13(3):184-90. PubMed ID: 4327420
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function.
    Wang W; Li J; Pan R; A S; Liao C
    Hepatol Int; 2015 Oct; 9(4):621-6. PubMed ID: 26208820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent studies of porto-arterial (parenchymo-connective tissue) circulatory disorder in Morgagni-Laennec cirrhosis and its importance in histopathogenesis of the disease process and in vascular surgical treatment].
    Paterni L
    Minerva Med; 1970 Nov; 61(91):5169-79. PubMed ID: 5489950
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fever in Morgagni-Laennec cirrhosis: contribution in clinical statistics].
    BASTAGLI D; ORLANDI G
    G Clin Med; 1949 Sep; 30(9):726-42. PubMed ID: 15394662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.